Literature DB >> 21444018

Inclusion body myositis: diagnosis, pathogenesis, and treatment options.

Guillermo E Solorzano1, Lawrence H Phillips.   

Abstract

Inclusion body myositis (IBM) is the most common acquired myopathy in people older than 50 years. IBM typically presents with distal upper extremity weakness accompanied by proximal lower extremity muscle weakness. Associated clinical findings include asymmetric weakness, foot drop, and dysphagia. The pathogenesis of IBM is not clear. In this article the authors briefly discuss postulated pathogenic mechanisms. Although no proven pharmacotherapy exists, some promising candidates are discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21444018     DOI: 10.1016/j.rdc.2011.01.003

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  1 in total

1.  BACE-1, PS-1 and sAPPβ Levels Are Increased in Plasma from Sporadic Inclusion Body Myositis Patients: Surrogate Biomarkers among Inflammatory Myopathies.

Authors:  Marc Catalán-García; Glòria Garrabou; Constanza Morén; Mariona Guitart-Mampel; Ingrid Gonzalez-Casacuberta; Adriana Hernando; Jose Miquel Gallego-Escuredo; Dèlia Yubero; Francesc Villarroya; Raquel Montero; Albert Selva O-Callaghan; Francesc Cardellach; Josep Maria Grau
Journal:  Mol Med       Date:  2015-11-03       Impact factor: 6.354

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.